[Initial Clinical Experiences Using Ocriplasmin for the Treatment of Vitreomacular Traction with or without a Macular Hole]. / Stellenwert von Ocriplasmin bei der Therapie der vitreomakulären Traktion mit und ohne Makulaforamen ­ erste klinische Erfahrungen.

PURPOSE: In vitreomacular traction (VMT), there is abnormal adhesion between the vitreous cortex and the retina, especially in the fovea. Symptoms of VMT include metamorphopsia and a decrease in visual acuity. Since 2013, ocriplasmin (Jetrea®) has been approved for treatment of symptomatic vitreomacular traction with or without macular holes (≤ 400 µm). METHODS: We retrospectively examined twenty-three eyes of twenty-one patients who underwent intravitreal ocriplasmin treatment for symptomatic vitreomacular traction with or without macular holes. Best corrected visual acuity and central retinal thickness (CRT) were measured in advance and after ocriplasmin treatment. The numbers of resolved vitreomacular traction and closed macular holes were documented. RESULTS: Vitreomacular traction was resolved in eight of twenty-three eyes (34.8 %); in fifteen eyes (65.2 %) it was persistent and two of four macular holes were found closed. The average best corrected visual acuity was 0.39 ± 0.25 logMAR at baseline and 0.41 ± 0.24 logMAR at the first follow-up visit after injection (p = 0.613). The average CRT was 453.3 ± 172.7 µm at baseline, with a slight decrease to 412.0 ± 212 µm (p = 0.124). CONCLUSION: Intravitreal injection of ocriplasmin appears is an experimental therapy in patients with symptomatic vitreomacular traction. Patient selection seems to be critically important for the therapeutic outcome, whereas greater age, specific VMT morphology and missing chromatopsia seem to be negative predictors.

[Methotrexate in Atypical Non-Arteritic Ischemic Optic Neuropathy]. / Methotrexat bei atypischer nicht arteriitischer anteriorer ischämischer Optikusneuropathie.

Background: Optic nerve disease can occur from a variety of different causes, with vascular, inflammatory or toxic pathologies. In such cases, it is hardly possible to clarify the aetiology. These diseases of the optic nerve are usually accompanied by progressive loss of visual field and visual impairment. Patient: We report a case of a 74-year-old woman complaining of loss of visual acuity, visual and blurred vision in the left eye in 2010. We made the diagnosis of non-arteritic ischemic optic neuropathy (NAION). With steroid therapy, there was an improvement in both visual acuity and visual field defects. But if an attempt was made to reduce steroids, her condition progressed. Except for a very small optic disk and arterial hypotension, there were no typical risk factors for NAION. We started treatment with methotrexate (MTX), with a starting dose of 10 mg per week, and observed the patient over two years. Results: Using MTX therapy, the swelling of the optic nerve head and visual field loss were reversible, so we increased the dose of MTX up to 15 mg/week. Steroid therapy could be stopped and the patient's visual acuity and visual field have now been stable for two years. There was no visible pallor in the optic nerve head, as normally occurs after AION, so we considered different underlying pathologies, including autoimmune disease. There were no adverse events with MTX therapy. Conclusion: If the course of the disease is atypical, the pathology may include an autoimmune component. Immunosuppressive MTX therapy may be started in order to avoid long-term steroid use. It may then be possible to maintain a stable visual field and prevent remitting episodes.

[Effectiveness of Intravitreal Aflibercept Injections in Patients who had Received 10 and More Ranibizumab Injections in Advance]. / Wirksamkeit von Aflibercept bei Patienten mit mehr als 10 vorangegangenen intravitrealen Ranibizumab-Injektionen.

BACKGROUND: Since 2007, the standard treatment for age related macular degeneration has been intravitreal injection of ranibizumab. However, despite continuous treatment, some patients fail to achieve remission or stabilisation of the disease. Since 2012, the recombinant fusion protein aflibercept has been available as an alternative treatment. In this study, we investigated whether patients who appear to be resistant to ranibizumab would benefit from treatment with aflibercept. METHODOLOGY: This retrospective study covered 83 eyes of 81 patients, for whom treatment switch from ranibizumab to aflibercept was indicated. Inclusion criteria were an age ≥ 50 years and at least 10 ranibizumab injections before a switch to aflibercept. Patients with severely impaired visual acuity were excluded. Primary outcomes were improvement or loss of visual acuity (VA) and evaluation of central macular thickness (CMT) via SD-OCT. Secondary endpoints were percentage of eyes without activity of the choroidal neovascular membrane after aflibercept injections and loss or gain of letters on the visual chart. Statistical analysis was performed using SPSS. RESULTS: VA was 0.83 ± 0.34 logMAR before the first aflibercept injection, with a slight but not statistically significant improvement up to 0.79 ± 0.33 logMAR after the third aflibercept injection (p = 0.205). On the other hand, there was a clear reduction of CMT in OCT, from 451.4 ± 263.0 to 288.2 ± 128.2 µm (p = 0.0001). Overall, 73 % of eyes exhibited better or stable VA and 27 % of eyes lost VA. Interestingly, eyes with worse initial VA gained greater benefit from the switch to aflibercept (p = 0.001). CONCLUSION: A switch to aflibercept may lead to stabilisation of choroidal neovascularisation and thus stabilise the visual acuity for patients who appear to be no longer responsive to treatment with ranibizumab.

[Effectivity of an occlusion-supporting PC-based visual training programme by horizontal drifting sinus gratings in children with amblyopia]. / Webbasierte Stimulationstherapie bei Kindern mit unbehandelter Amblyopie.

BACKGROUND: The studies of Kämpf et al. suggested an efficiency of a computer-based stimulation therapy by drifting sinus gratings in patients with anisometropic and/or strabismic amblyopia but provided no clear evidence. This is the first trial with amblyopic patients without previous treatment at the beginning of amblyopia therapy. METHODS: A prospective, randomised, single-blinded, placebo-controlled study of n = 15 patients with anisometropic and/or strabismic amblyopia without previous treatment was performed. Age of the patients was between 4 and 10 years, mean 6.3 years (± 2.0), all after full correction of refraction errors and refractive adaptation. Stimulation therapy was performed 5 times a week over 4 weeks, respectively 2 × 20 min, a drifting sinus grating of constant spatial and temporal frequency was combined with computer games (n = 8). Control group had only computer games with a neutral background (n = 7). In both groups patching was only done in stimulation times. RESULTS: Stimulation and control group did not differ due to age, gender, and cause of amblyopie, baseline visual acuity, and time of wearing glasses. There was no significant difference in the development of visual acuity over the stimulation period between stimulation and control groups. CONCLUSIONS: Stimulation therapy with drifting sinus gratings did not improve the development of visual acuity in the first phase of amblyopia treatment combined with minimal occlusion therapy. Accordingly, the stimulation therapy is not adequate to replace sufficient occlusion therapy. Whether this therapy could support patching therapy and improve acuity development in later therapy phases cannot be assumed from this trial.

[Collagen cross-linking with riboflavin and UVA light]. / Kollagenvernetzung mit Riboflavin und UVA-Licht.

PURPOSE: Since 1998 collagen cross-linking is used for patients with progressive keratoconus. Today it can almost be considered as the standard therapy. METHODS: Patients with progressive keratoconus and minimal corneal thickness of 400 µm have been cross-linked within a study - (EK 310 499) approved by the ethical committee since 1998. An increase of the maximum K-value by ≥ 1 D within the last year, patient's statement of deteriorating visual acuity or the necessity of new contact len fitting more than once in 2 years were considered as progression. RESULTS: The analysis includes 153 eyes of 111 patients with a minimal follow-up of 12 months and a maximum follow-up of 6 years. The keratectasia significantly decreased in the 1 (st) year by 2.28 D. The visual acuity improved significantly by at least one line or, respectively, remained stable (i. e., no line loss) in the 1st year in 73 %. The results remained stable over the next two years. Despite the low number of patients with a follow-up longer than 3 years and therefore limited statistical statement power, our results still indicate a long-term stabilisation or, respectively, improvement after collagen cross-linking. We saw no severe side-effects. Three patients with an exacerbated neurodermitis showed continuous progression of keratoconus and were cross-linked again. CONCLUSIONS: To date there have been numerous promising publications on collagen cross-linking for keratoconus. The results of this study indicate that collagen cross-linking appears to be an effective therapeutic option for progressing keratoconus. Besides the clinical there are enormous economical and psychosocial benefits. Cross-linking is an out-patient, minimally-invasive, cost-effective treatment with minimal strain for the persons concerned.

[Statistical analysis of correlated measurement data in ophthalmology : Tutorial for the application of the linear mixed model in SPSS and R using corneal biomechanical parameters]. / Statistische Auswertung korrelierter Messdaten in der Augenheilkunde : Tutorial zur Verwendung des linear gemischten Modells in SPSS und R anhand biomechanischer Parameter der Hornhaut.

BACKGROUND: In ophthalmology data from both eyes of a person are frequently included in statistical analyses. As correlated data are used this procedure contradicts the independency principle for classical statistical tests, such as Student's t­test and analysis of variance (ANOVA). In this tutorial a new possibility is presented in which data from both eyes can be used for statistical analysis. OBJECTIVE: The statistical approach of linear mixed models (LMM) was used to take correlated data of both eyes of patients into account. METHODS: The LMM is available in several statistical software packages, e.g. SPSS and R, and allows the inclusion of measurement data from both eyes of a person in the statistical analysis. The application was tested on data from a biomechanical characterization of the cornea from healthy participants assessed with the dynamic Scheimpflug analyzer (Corvis ST; Oculus, Wetzlar, Germany). RESULTS: A total of 158 eyes from 79 healthy participants were included. A strong correlation between the right and left eyes of the participants could be observed with respect to the analyzed parameters. Comparison of the biomechanical parameters between the different age groups showed that P-values were increased when using the LMM compared to the ANOVA. Older participants (56-79 years) showed a significantly shorter time to the second applanation (P = 0.002), a significantly increased eyeball movement during the deformation (P = 0.001) and a significantly higher stiffness at the first applanation (P = 0.006) compared to younger participants (18-35 years). CONCLUSION: The analysis of measurement data from both eyes using classical statistical tests, without the consideration of the correlation, leads to an overestimation of the statistical power. This can be avoided by implementation of the LMM.

[Unusual coloboma of the optic disc?] / Ungewöhnliches Optikuskolobom?

A twelve-year old girl presented herself for a routine ophthalmologic examination in our clinic. Best-corrected visual acuity (BCVA) was 1.0 on both eyes. On funduscopic examination we saw a yellow round structure inferior to the optic nerve head. In optical coherence tomography (OCT) examination the structure showed cupping and opening of the Bruch membrane and retinal pigment epithelium (RPE). Visual field testing revealed an absolute scotoma right in the area were the abnormal coloboma was localized. We diagnosed a pseudo-doubling of the optic disk, which is a rare condition with just a few reports about it in the literature. This finding is harmless and requires no treatment.

[Enzymatic evidence of the depth dependence of stiffening on riboflavin/UVA treated corneas]. / Enzymatischer Nachweis der Tiefenabhängigkeit der Vernetzungswirkung von Riboflavin/UVA an der Hornhaut.

PURPOSE: It has been shown that the treatment of keratoconus with riboflavin/ultraviolet A (UVA) causes significant stiffening of the cornea due to cross-linking. The aim of this study was to evaluate how deep the mechanical stabilization after collagen cross-linking could be shown biochemically. METHOD: Ten out of 20 enucleated porcine eyes were treated with riboflavin as a photosensitizer and UVA (370 nm, 3 mW/cm2, 30 min). The other 10 eyes served as controls. With a Microkeratom device, two flaps with a thickness of 200 microm and a diameter of 8 mm were cut off from each eye and put in a collagenase solution (NaCl plus collagenase A, 1:1). The surfaces of the flaps were measured digitally every day to characterize the dissolving behavior. RESULTS: The resistance (regarding corneal collagen against enzymatic digestion) of the treated superficial flaps was considerably higher (p=0.001) compared to those that were cut secondarily and to the control flaps. But even the flaps from deeper layers showed a significant increase in resistance (p=0.02) compared with the untreated flaps. The half-life of the surfaces of the treated superficial flaps was 220 h; of those cut secondarily, it was 80 h. Both untreated flaps had a half-life of 50 h. CONCLUSIONS: The biochemical study showed that the treatment of the cornea with riboflavin/UVA leads to significant collagen cross-linking not only in the anterior slice of 200 microm but also in the following 200 microm. This locally limited cross-linking effect may be explained by the absorption behavior for UVA of the riboflavin-treated cornea; 65% of UVA irradiation is absorbed in the first 200 microm and only 25-30% in the next 200 microm. Therefore, deeper-lying structures and especially the endothelium are not affected.

[Severe Aspergillus endophthalmitis occurring after liver transplantation in an 8-month-old baby]. / Aspergillus-Endophthalmitis nach Lebertransplantation bei einem Säugling.

Immunosuppressed patients and transplant patients bear an increased risk for invasive aspergillosis and Aspergillus endophthalmitis. An 8-month-old boy developed severe unilateral panuveitis after liver transplantation. Bronchopulmonary infiltrates were present, but a pulmonary Aspergillus infection was not confirmed. An enucleation was performed in order to prevent a life-threatening disseminated Aspergillus infection.

[Dynamic Scheimpflug Analyzer (Corvis ST) for measurement of corneal biomechanical parameters : A praxis-related overview]. / Dynamischer Scheimpflug-Analyzer (Corvis ST) zur Bestimmung kornealer biomechanischer Parameter : Ein praxisbezogener Überblick.

BACKGROUND: Topographic and tomographic parameters alone are often not sufficient for early detection of corneal changes. Pathological alterations in the microstructure of the cornea occur before changes in topography and tomography can be detected. Biomechanical parameters show a strong correlation with microscopic structural changes. OBJECTIVE: The aim of the study was to gain information about the microscopic structure and consistency of the cornea by measuring biomechanical parameters. MATERIALS AND METHODS: The deformation behavior of the cornea was analyzed with the Dynamic Scheimpflug Analyzer (Corvis ST; OCULUS, Wetzlar, Germany). Deformation parameters and biomechanical indices were derived from the deformation response of the cornea. RESULTS: Deformation parameters and indices in keratoconus patients differ significantly from healthy subjects. Alterations of the cornea can be detected before topographic and tomographic changes occur. The repeatability and reproducibility of relevant deformation parameters is good to very good. In glaucoma patients a modified deformation behavior of the cornea can be observed, which might be related to structural changes. CONCLUSION: The Corvis ST allows a reliable characterization of the tissue structure and consistency of the cornea.

[Comparative measurements of central corneal thickness with two ultrasound pachymeters]. / Vergleichende Messung der zentralen Hornhautdicke mit zwei Ultraschallpachymetern.

BACKGROUND: The aim of this study was to compare two different ultrasound pachymeters based on measurements of central corneal thickness (CCT). METHODS: CCT of 1,070 eyes of 535 patients (glaucoma and glaucoma suspects) was determined using the ultrasound pachymeter IOPac (Heidelberg Engineering, Germany) and SP-3000 (Tomey Corporation, Japan). With the IOPac 8 measurements are averaged by the instrument and with the SP-3000 200 measurements, respectively. For statistical purposes intraclass correlation coefficients (ICC) and Bland-Altman analysis were calculated. RESULTS: The mean CCT was 561.3+/-35.6 microm (IOPac) and 561.8+/-35.6 microm (SP-3000). The mean difference between both pachymeters was 0+/-8 microm. ICC was 0.9746 (95% confidence interval: 0.9714-0.9774). CONCLUSIONS: The use of the two instruments tested has no influence on the determination of CCT. The measured CCT of glaucoma patients or suspects were slightly above the CCT of normals of other studies.

[Measurement of peripapillary nerve fiber layer thickness at different distances from the optic nerve head with OCT]. / Bestimmung der peripapillären Nervenfaserschichtdicke mit der optischen Kohärenztomographie (OCT) in verschiedenen Abständen zum Papillenrand.

PURPOSE: The aim of this study was to assess which distance to the optic nerve head is most favorable for circular measurements of retinal nerve fiber layer thickness (RNFLT) with OCT to detect differences between glaucoma and normal subjects. METHODS: A total of 98 eyes of 67 subjects (normal subjects and POAG patients) were examined by Stratus OCT (Zeiss, Model 3000, Software Version 2.0). Images were scanned in the "proportional circle" mode and analyzed with the "RNFL thickness analysis" protocol. For statistical analysis the Friedman test and the Mann-Whitney U test with Bonferroni correction were used. RESULTS: For 23 normal and 19 eyes of POAG patients a complete set of scans could be analyzed by the OCT software. RNFLT was statistically significantly different in scan diameters in both groups (P=0.000). Differences between the groups were statistically significant for the 1.0-fold (P=0.003), for the 1.4-fold (P=0.01), and for the 1.8-fold (P=0.002) disc diameter. CONCLUSION: Circular scans with a 1-fold and with a 1.8-fold disc diameter seem to be able to differentiate best between glaucoma and normal subjects.

[Intraocular pressure measurement during the day and night for glaucoma patients and normal controls using Goldmann and Perkins applanation tonometry]. / Augeninnendruckmessungen im Tages- und Nachtverlauf bei Glaukompatienten und Normalprobanden mittels Goldmann- und Perkins-Applanationstonometrie.

OBJECTIVE: Our aim was to evaluate intraocular pressure (IOP) levels in primary open angle glaucoma (POAG) patients and healthy controls during both the day and night while measuring in an upright as well as in a supine position. METHODS: In a prospective clinical trial, 30 glaucoma patients on topical treatment and 50 healthy controls received IOP measurements every 4 h for a 24 h period starting at 8 am. Additionally, blood pressure and heart rate were measured and perfusion pressures were calculated. At 12 am IOP was initially measured in a sitting position and then, after 20 min, in a supine position. At midnight this was carried out conversely. At 4 am IOP was measured in a supine position; all other measurements were performed in a sitting position. Measurements in the sitting position were performed by Goldmann and Perkins tonometry and in a supine position by Perkins tonometry. RESULTS: IOP was 1 mmHg lower in Perkins tonometry measurements compared to Goldmann tonometry. There was no difference between the two patient groups. In a supine position, IOP measured by Perkins tonometry was higher than in an upright position. At 12 am the difference was 1.8 mmHg+/-2.7 mmHg (p=0.001) in healthy subjects and 1.3+/-2.7 mmHg (p=0.013) in the POAG patients. At 12 pm the increase of IOP in the supine position was even more pronounced with 2.4+/-3.4 mmHg in healthy subjects and 5.6+/-3.2 mmHg in the POAG patients (p=0.001). The blood pressure and the perfusion pressure were lowest during night measurements. CONCLUSIONS: During diurnal IOP measurements in an upright position there were no statistically significant differences in IOP changes between groups. However, in a supine position IOP was significantly higher than in a sitting position and increased more in the glaucoma patients than in healthy controls. This observation might be due to a faulty regulation of the fluid shift in glaucoma patients and could cause progression of glaucomatous damage.

[Best's disease with normal EOG. Case report of familial macular dystrophy]. / Morbus Best mit normalem EOG. Fallvorstellung einer familiären Makuladystrophie.

Best's disease is an autosomal dominant disorder with incomplete penetrance and variable expression. A typical characteristic of Best's disease is a pathological EOG. We describe four members of a family with bilateral, subfoveal vitelliform lesions. The EOG was normal in all cases. Genetic analysis of the oldest son indicated a heterozygotic mutation Ala234Val in the VMD2 gene, so-called bestrophin gene, which is associated with Best's disease. Molecular genetic analysis also found Best's disease with a normal EOG. A normal EOG cannot exclude Best's disease. The family members should receive genetic consultation and if wished analysis of the VMD2 gene.

[Evaluation of focal arteriolar narrowing of retinal arterioles in glaucoma]. / Fokale Verengungen retinaler Arteriolen beim Glaukom.

PURPOSE: Vascular risk factors seem to play a role in the pathogenesis of glaucoma. This study was performed to compare the prevalence of focal arteriolar narrowing in glaucoma patients and normals. MATERIAL AND METHODS: Stereoscopic optic disc photographs of 40 normal subjects and 14 primary open-angle glaucoma (POAG) patients were reviewed independently in a masked fashion by two graders. Focal arteriolar narrowing within one disc diameter from the rim edge was evaluated based on two different methods: narrowing present if (1) the arteriole was wider distal to the narrowing and (2) if the arteriole was wider both distal and proximal to the narrowing. RESULTS: With both methods, focal arteriolar narrowing was significantly higher in glaucoma versus normal eyes. Focal arteriolar narrowing was observed with definition 1 in 35.0% of normals and 71.4% of POAG patients and with definition 2 in 12.5% of normals and 42.9% of POAG patients. CONCLUSIONS: Focal arteriolar narrowing is more frequent in glaucoma patients than in normals. Independent of the method for assessing arteriolar narrowing, however, the diagnostic value of arteriolar narrowing seems limited due to the high incidence in normals.

[Corneal collagen cross-linking with riboflavin and ultraviolet-A light in progressive keratoconus. Results after 10-year follow-up]. / Hornhautkollagenvernetzung mit Riboflavin und UVA-Licht bei Patienten mit progressivem Keratokonus : 10-Jahres-Ergebnisse.

PURPOSE: Riboflavin and ultraviolet-A induced cross-linking (CXL) is a promising therapeutic option to halt the progression of keratoconus. The aim of the study was to prove a long-term stabilizing effect of riboflavin and ultraviolet-A induced collagen CXL in young and otherwise healthy patients with progressive keratoconus and a corneal thickness of at least 400 µm on average 10 years after treatment. METHODS: Corneal CXL was performed after removing epithelial tissue by instilling riboflavin 0.1% solution for 30 min before and during 30 min of ultraviolet-A irradiation (370 nm, 3 mW/cm(2)). This long-term retrospective study included 30 eyes of 20 patients with progressive keratoconus. Preoperative and postoperative examinations on average 10 years after treatment included best corrected visual acuity (BCVA), corneal topography (keratometry values KMAX, KMIN and KApex), corneal thickness (CT) and if available endothelial cell density. RESULTS: The mean preoperative age was 28 ± 7 years (range 14-42 years), 4 patients were female (7 eyes) and 16 patients (23 eyes) were male. Preoperatively, the mean K-value on the apex of keratoconus was 62 ± 13.2 dpt which showed a statistically significant reduction after 10 years to 55 ± 8.1 dpt (p = 0.001). The mean KMAX (53 ± 8.2 versus 49 ± 6.6 dpt) and KMIN values (48 ± 5.5 vs. 45 ± 5.1 dpt) also showed a statistically significant decrease (p = 0.001). In comparison BCVA also showed a statistically significant preoperative and postoperative difference (p = 0.005). There was a significant improvement of BCVA by a mean of - 0.13 ± 0.25 logMAR. The mean change in corneal thickness at the 10-year follow up was 46 µm (p = 0.001). Bias possibly occurred because of a change of the measurement method from ultrasound pachymetry to optical pachymetry with Oculus Pentacam®. Neither corneal endothelium nor deeper structures suffered any damage. Only two patients had continuous progression of keratoconus and needed a reapplication of CXL. CONCLUSION: The results of this study indicate that riboflavin and ultraviolet-A induced corneal CXL is a promising therapeutic option for progressing keratoconus to obtain long-term stabilization. There was a sustained improvement of all K-values and BCVA 10 years after treatment and CXL is minimally invasive and easy to handle. Side effects, such as endothelial damage did not occur.

The visual response to increased ocular blood flow in normal pressure glaucoma.

The vascular reactivity to breathing carbon dioxide represents a widely used method in neurology to diagnose microvascular cerebral disorders. Fifteen eyes of 15 patients suffering from confirmed normal pressure glaucoma were included in the study. The ocular carbon dioxide reactivity was determined by recording ocular pulse amplitudes (OPA) by means of oculo-oscillo-dynamography (OODG). The initial pulse amplitudes were found to be comparable to healthy subjects. According to the results obtained during breathing increased carbon dioxide concentrations (95% O2; 5% CO2; endtidal CO2 approx. 6.5%), the collective of 15 patients could be subdivided into two subgroups. One group (n = 9) showed a carbon dioxide reactivity that was comparable to healthy subjects, i.e., an increase of ocular pulse amplitudes of 57%. The remaining six eyes, however, showed a statistically significantly higher OPA increase compared to the first subgroup. According to the results obtained and to evaluate the hypothesis that these hemodynamic changes are accompanied by functional improvements, central visual fields were performed during breathing room air or increased inspiratory carbon dioxide concentrations. After exposure to carbon dioxide the visual fields improved significantly in patients who showed a significant increase in OPA. An increased carbon dioxide reactivity in some normal pressure glaucoma patients, i.e., a significant increase of OPA and a significant improvement of the central visual field during exposure to increased inspiratory carbon dioxide concentrations, may be due to an initial ocular vasospasm in these patients, which can be released by induced vasodilation due to carbon dioxide exposure.

Intraocular pressure after replacement of current dual therapy with latanoprost monotherapy in patients with open angle glaucoma.

AIMS: To evaluate the efficacy and safety of replacing current dual ocular hypotensive therapy with latanoprost 0.005% monotherapy in patients with open angle glaucoma. METHODS: This randomised, open label, parallel group, multinational study included 466 patients with open angle glaucoma currently on dual ocular hypotensive therapy, including a beta adrenergic receptor antagonist. Patients were assigned (1:3) to ongoing dual therapy or a switch to monotherapy with latanoprost 0.005% once daily for 6 months. Intraocular pressure (IOP) was measured at 10 am and 5 pm at baseline, month 3, and month 6. Groups were compared for differences in diurnal IOP change, IOP success rates (IOP < or =22 mm Hg with < or =15% increase from baseline), and clinical success rates (not requiring change in therapy). RESULTS: Baseline mean diurnal IOP was 17.8 (SD 2.0) mm Hg in the latanoprost group and 17.6 (2.1) mm Hg in the dual therapy group. After 6 months, mean diurnal IOP was reduced by 0.26 (0.18) (SEM 1.4%) mm Hg (p=0.153) in the group switched to latanoprost and by 0.37 (0.25) (2.1%) mm Hg (p=0.138) in those continuing dual therapy (difference: 0.11 mm Hg; p=0.641). Success rates defined by IOP criteria were 83% for latanoprost and 89% for continued dual therapy (difference: 6%; p=0.122). Clinical success rates were 97% for latanoprost and 99% for dual therapy (difference: 2%; p=0.161). Ocular adverse events were reported by 23% of patients in both treatment groups. CONCLUSION: Latanoprost monotherapy is a safe and effective alternative for many patients with open angle glaucoma requiring dual topical ocular hypotensive therapy for IOP control.

Pressure compliance of the optic nerve head in low tension glaucoma.

Twenty eyes of 10 healthy subjects, 11 eyes of seven patients with low tension glaucoma, and three eyes of three patients with ischaemic optic neuropathy were investigated. Visual evoked responses were recorded under stepwise artificially increased intraocular pressures. The results of the visual evoked response recording (pressure compliance test) allow a clear distinction to be made between healthy subjects, patients with low tension glaucoma, and patients with ischaemic optic neuropathy. In the groups investigated a lack of autoregulation of the optic nerve head circulation was found in patients with low tension glaucoma only. Patients with anterior ischaemic optic neuropathy showed the same pressure compliance behaviour as healthy subjects. The methods used here seem to provide a practicable clinical tool in the differential diagnosis of low tension glaucoma.